Neurotech industry news
Funding rounds, product launches, research findings, and policy updates — published 3× per week.
ProductIt's Finally Here: FacialDx, an AI-Powered Support Tool for Sideline Concussion Assessments
FacialDx analyzes over 13,000 facial variables and 155 biomarkers to deliver neurological wellness indicators in seconds — giving clinicians objective data for sideline concussion decisions.
2026-06-23
ResearchMIT Researchers Demonstrate Real-Time Emotion Decoding via Non-Invasive EEG with 94% Accuracy
MIT's new EEG-based system decodes six discrete emotional states in real time with 94% accuracy, a landmark for non-invasive affective neuroscience.
2026-06-13
ProductSynchron Launches Stentrode Home Edition, Expanding BCI Access Beyond Clinical Settings
Synchron's Stentrode Home Edition brings endovascular BCI technology to approved patients outside hospital walls for the first time.
2026-06-11
IndustrySynchron Reaches 100-Patient Milestone as Stentrode BCI Moves Toward Pivotal Trial
Synchron's implantable brain-computer interface has now been placed in 100 patients globally, setting the stage for a pivotal FDA trial later this year.
2026-06-09
ResearchClosed-Loop Deep Brain Stimulation Demonstrates Sustained Cognitive Benefits in Landmark Alzheimer's Trial
A 24-month adaptive DBS trial reports significant memory retention improvements in early-stage Alzheimer's patients, reshaping neuromodulation research.
2026-06-04
PolicyFDA Finalizes Guidance Framework for Adaptive Neural Devices, Setting Clearer Path for BCI Approvals
The FDA's finalized guidance on adaptive neural devices establishes new evidentiary standards for BCI approvals, reshaping the regulatory landscape.
2026-05-30
Sponsored content
Reach neurotech decision-makers with your story
Sponsored articles appear in the News feed and the weekly newsletter. $1,500/article.